19 search results for: disease modification

ADVENT On Air | Early Intervention and <b>Disease</b> <b>Modification</b> in Atopic Dermatitis

Podcast

ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis

20 min

Dermatology

Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.

Podcast

ADVENT On Air | Charting a New Course: The Frontier of Early Intervention and Disease Modification in AD

23 min

Dermatology

Join Drs. April Armstrong and Lisa Beck for a conversation around the long-term burden and effects of AD. They will discuss the underlying pathophysiology of AD and how early intervention and disease modification may impact disease course.

New Perspectives on <b>Disease</b> <b>Modification</b> in Atopic Dermatitis

expert video

New Perspectives on Disease Modification in Atopic Dermatitis

48 min

Dermatology

An exploration into the concept and potential of disease modification through therapeutic interventions in AD.

Exploring The Concept of <b>Disease</b> <b>Modification</b> in Atopic Dermatitis

expert video

Exploring The Concept of Disease Modification in Atopic Dermatitis

13 min

Dermatology

Exploring the concept of disease modification and related pathomechanisms in atopic dermatitis.

New Perspectives on <b>Disease</b> <b>Modification</b> in Atopic Dermatitis - Panel Discussion

expert video

New Perspectives on Disease Modification in Atopic Dermatitis - Panel Discussion

10 min

Dermatology

Panel discussion exploring what disease modification could involve in atopic dermatitis.

How Can We Explore the Concept of <b>Disease</b> <b>Modification</b> in Children With AD?

expert video

How Can We Explore the Concept of Disease Modification in Children With AD?

2 min

Dermatology

Dr. Lawrence Eichenfield discusses the concept of disease modification in children with AD.

<b>Disease</b> <b>Modification</b> in AD

expert video

Disease Modification in AD

3 min

Dermatology

In this highlight video from the May 2024 ADVENT symposium at ESPD’s Annual Meeting in Košice, Slovakia, Dr. Amy Paller discusses the benefits of early intervention for children with AD and the potential for disease modification.

Early Intervention and the Potential for <b>Disease</b> <b>Modification</b> in Children With AD

expert video

Early Intervention and the Potential for Disease Modification in Children With AD

15 min

Dermatology

This video from the May 2024 ADVENT symposium at ESPD’s Annual Meeting in Košice, Slovakia features Dr. Amy Paller discussing the benefits of early intervention for children with AD and the potential for disease modification. Dr. Paller also reviews available data investigating the impacts of therapies for AD on the disease itself and on associated comorbidities.

Considerations for <b>Disease</b> <b>Modification</b> in AD

expert video

Considerations for Disease Modification in AD

3 min

Dermatology

In this highlight video from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, Dr. Eric Simpson explores potential considerations when discussing the concept of disease modification and how early intervention might be disease modifying in AD.

Early Intervention and the Potential For <b>Disease</b> <b>Modification</b> in AD

expert video

Early Intervention and the Potential For Disease Modification in AD

5 min

Dermatology

In this expert interview video focusing on topics from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, Dr. Eric Simpson discusses key considerations for disease modification and the importance of early intervention in treating patients with AD.

The Impact of Advanced Systemic Therapies on <b>Disease</b> Control and Potential Remission in Atopic Dermatitis

expert video

The Impact of Advanced Systemic Therapies on Disease Control and Potential Remission in Atopic Dermatitis

10 min

Dermatology

Exploring the concept of disease modification relating to therapeutic interventions with targeted systemic therapies in atopic dermatitis.

expert video

How the Understanding of PN has Evolved?

2 min

Dermatology

Dr Kwatra poses the question: How do we assess disease modification in PN, and can treating early stop tissue damage and worsening of systemic diseases associated with PN?

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region